Masked trial of topical anesthesia for retinopathy of prematurity eye examinations

Martin S Cogen1, Jack S Parker, Todd E Sleep

  • 1Department of Ophthalmology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 35233, USA. mcogen@uab.edu

Insights

Topical anesthetic use in premature infants undergoing retinopathy of prematurity (ROP) examinations appears to reduce pain. This intervention showed no adverse effects on corneal clarity during these crucial eye exams.

Area of Science:

  • Ophthalmology
  • Neonatal Care
  • Pain Management

Background:

  • Retinopathy of prematurity (ROP) requires regular eye examinations in premature infants.
  • Assessing pain and corneal clarity during ROP examinations is critical for infant well-being and diagnostic accuracy.

Purpose of the Study:

  • To evaluate the impact of a topical anesthetic on pain and corneal clarity in premature infants during ROP examinations.
  • To compare the efficacy of proparacaine 0.5% versus artificial tears for pain reduction.

Main Methods:

  • Premature infants undergoing ROP examinations were randomized.
  • One eye received proparacaine 0.5% or artificial tears; the other received artificial tears.
  • Pain was assessed using the Premature Infant Pain Profile (PIPP); corneal clarity was compared between eyes.

Main Results:

  • A topical anesthetic (proparacaine 0.5%) was associated with a lower incidence of painful events (27% vs. 65%).
  • Mean PIPP scores were lower in the anesthetic group (8.8 vs. 10.4), though not statistically significant (p=0.17).
  • No adverse effects on corneal clarity were observed with anesthetic use.

Conclusions:

  • Topical anesthetic use may offer a marginal decrease in pain during ROP examinations.
  • Proparacaine 0.5% does not negatively impact corneal clarity in this population.
  • Anesthetics are a safe option for managing pain during ROP screening.
Abstract

Related Concept Videos